These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 908015

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mammary tumor growth inhibition in C3H/He mice by long-term Bacillus Calmette-Guérin immunoprophylaxis versus enhancement by primary Bacillus Calmette-Guérin therapy.
    Vaage J.
    Cancer Res; 1983 Dec; 43(12 Pt 1):5778-82. PubMed ID: 6357431
    [Abstract] [Full Text] [Related]

  • 4. Single versus double preoperative intralesional BCG in 13762 mammary adenocarcinoma.
    Lee YT.
    J Surg Oncol; 1979 Dec; 12(3):243-52. PubMed ID: 502566
    [Abstract] [Full Text] [Related]

  • 5. Comparative antitumor effects of Corynebacterium parvum, Bordetella pertussis, Bacillus Calmette-Guérin, and levamisole alone or in combination with cyclophosphamide in the CaD2 murine mammary adenocarcinoma system.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG, Kontra J.
    Cancer Res; 1979 Dec; 39(12):4838-42. PubMed ID: 498111
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intralesional Bacillus Calmette-Guérin immunotherapy of canine venereal tumors.
    Hess AD, Catchatourian R, Zander AR, Epstein RB.
    Cancer Res; 1977 Nov; 37(11):3990-4. PubMed ID: 143344
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of bacillus Calmette-Guérin-induced nitric oxide in bladder tumor cells may improve BCG treatment.
    Alvarez V, Lodillinsky C, Umerez S, Sandes E, Eiján AM.
    Int J Mol Med; 2005 Oct; 16(4):565-71. PubMed ID: 16142388
    [Abstract] [Full Text] [Related]

  • 9. Bacillus Calmette-Guérin and dinitrochlorobenzene immunotherapy of chemically induced bladder tumors.
    Lamm DL, Harris SC, Gittes RF.
    Invest Urol; 1977 Mar; 14(5):369-72. PubMed ID: 844999
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Experimental cancer immunotherapy: comparison of tumor rejection if F344 rats given live Mycobacterium bovis (Strain BCG) and killed Corynebacterium parvum.
    Likhite VV.
    J Natl Cancer Inst; 1976 May; 56(5):985-9. PubMed ID: 994209
    [Abstract] [Full Text] [Related]

  • 16. Influence of immunotherapeutic agents on the progression of spontaneously arising, metastasizing rat mammary adenocarcinomas of varying immunogenicities.
    Greager JA, Baldwin RW.
    Cancer Res; 1978 Jan; 38(1):69-73. PubMed ID: 618584
    [No Abstract] [Full Text] [Related]

  • 17. The antimetastatic effect of IV-inoculated BCG on adenocarcinomas in the prostate-seminal vesicle complex of L-W rats.
    Pollard M, Luckert PH.
    Anticancer Res; 1994 Jan; 14(3A):901-3. PubMed ID: 8074491
    [Abstract] [Full Text] [Related]

  • 18. Immunotherapy of established micrometastases with Bacillus Calmette-Guérin tumor cell vaccine.
    Hanna MG, Peters LC.
    Cancer Res; 1978 Jan; 38(1):204-9. PubMed ID: 201374
    [Abstract] [Full Text] [Related]

  • 19. Influence of surgery, irradiation, chemotherapy, and immunotherapy on growth of a metastasizing rat mammary adenocarcinoma.
    Bogden AE, Esber HJ.
    Natl Cancer Inst Monogr; 1978 Dec; (49):97-100. PubMed ID: 748802
    [Abstract] [Full Text] [Related]

  • 20. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study.
    Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA, Sarosdy MF, Bohl RD, Grossman HB, Beck TM, Leimert JT, Crawford ED.
    J Urol; 2000 Apr; 163(4):1124-9. PubMed ID: 10737480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.